SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that company management will participate in TD Cowen’s 44th Annual Health Care Conference and Leerink Partners Global Biopharma Conference 2024. Details of participation are as follows: TD Cowen 44th Annual Health Conference
Format: Genetic Medicines Panel
Time: 2:10 PM ET – 3:10 PM ET
Leerink Partners Global Biopharma Conference 2024
Time: 10:40 AM ET – 11:10 AM ET
The live presentations will be webcast and may be accessed from the Investors section of Tenaya’s website. A replay of the webcasts will be available on the Tenaya website for approximately 30 days following each conference.
ContactsInvestorsMichelle CorralAnne-Marie FieldsVP, Corporate Communications and Investor RelationsStern Investor RelationsIR@tenayathera.comAnnemarie.fields@sternir.com